Neal James R
SEC insider (Form 3/4/5 filer). CIK 0001600865. Director at Processa Pharmaceuticals, Inc. (PCSA) and 2 other issuers. 18 reported Form 4/5 transactions since Sep 2024; latest on Jul 26, 2026. Located in VERO BEACH, FL.
Companies Neal James R has filed insider reports for
- Processa Pharmaceuticals, Inc. (PCSA): Director
- Akari Therapeutics Plc (AKTX): Director
- Peak Bio, Inc. (PKBO): Director
Neal James R
CIK: 0001600865
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jul 26, 2026PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
62.2K shares- - Mar 31, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect789 shares at avg. $2.54$2K - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
2.5K shares at avg. $0.40- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase American Depositary Shares ("ADRs")
2.5K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase ADRs
3.1K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
3.1K shares at avg. $0.40- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectStock Options (Right to Buy)
300K shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
100K shares- - Jul 24, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock
175.3K shares- - Mar 20, 2025AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
225K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 26, 2026 |  PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 62,221 | - | - | Direct |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 789 | $2.54 | $2,000 | Direct |
| Dec 16, 2025 |  AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 2,473 | $0.40 | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase American Depositary Shares ("ADRs") | 2,473 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase ADRs | 3,093 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 3,093 | $0.40 | - | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Stock Options (Right to Buy) | 300,000 | - | - | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 100,000 | - | - | Direct |
| Jul 24, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock | 175,299 | - | - | Direct |
| Mar 20, 2025 | AKTX Akari Therapeutics Plc | Award Stock Option (Right to Buy) | 225,000 | - | - | Direct |
1-10 of 18 transactions